AstraZeneca Canada Inc.

What they're asking for

In the registry's own words. Descriptions are only filed for meetings since mid-2024.

1. Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes

   June 25, 2026 · Mark Carney · Liberal · Government Procurement; Health; Industry; Intellectual Property; International Trade

2. Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations

   June 17, 2026 · Marjorie Michel · Liberal · Government Procurement; Health; Industry; International Trade; Budget

3. Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry

   May 7, 2026 · Dan Mazier · Conservative · Government Procurement; Health; Industry; Intellectual Property; International Trade

4. Patent Act, Patented Medicines (Notice of Compliance) Regulations, Data Protection Regulation, Certificates of Supplementary Protection and related policies regarding the regulation of intellectual property for biopharmaceutical products, and maintaining international competitiveness.

   October 22, 2025 · Matt Jeneroux · Liberal · Health; Intellectual Property; International Trade; Taxation and Finance; International Development

5. Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry

   July 18, 2025 · Mélanie Joly · Liberal · Health; International Trade; Taxation and Finance; Research and Development; Economic Development

6. Updates to, and implementation of, the Biomanufacturing and Life Sciences Strategy to support investments in Canada.

   December 12, 2024 · François-Philippe Champagne · Liberal · Health; Industry; Science and Technology; Research and Development

Full meeting log

25 MP-directed communications since January 2024, from the Registry of Lobbyists.